25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization
Introduction: Somatization disorder is a debilitating condition, in which patients have multiple physical complaints with no explained cause and no relief even after consultations. Aim: The present study examined the association of 25-hydroxyvitamin D (25[OH]D) levels, quality of life, disability, a...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Industrial Psychiatry Journal |
Subjects: | |
Online Access: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=87;epage=91;aulast=Srivastava |
_version_ | 1818479180945293312 |
---|---|
author | Shruti Srivastava Manjeet Singh Bhatia Priyanka Gautam |
author_facet | Shruti Srivastava Manjeet Singh Bhatia Priyanka Gautam |
author_sort | Shruti Srivastava |
collection | DOAJ |
description | Introduction: Somatization disorder is a debilitating condition, in which patients have multiple physical complaints with no explained cause and no relief even after consultations. Aim: The present study examined the association of 25-hydroxyvitamin D (25[OH]D) levels, quality of life, disability, and symptom profile in long standing with somatization disorder. Methods: One-hundred three patients of somatization disorder suffering for ≥2 years, visiting psychiatry outpatient clinic during two consecutive summer season (April to June) of 2015–2016 were recruited. Symptom profile was studied using Patient-Health-Questionnaire (PHQ-15) items (somatic symptoms), PHQ-9 items (depressive symptoms), Generalized Anxiety Disorder-7 (GAD-7) item (anxiety symptoms).quality of life was assessed using the World Health Organization Quality of Life BREF 26 item, and disability measure was World Health Organization Disability Assessment Schedule (WHODAS) 2.0. 25(OH) D levels were estimated using chemiluminescence binding assay. Results: The poor quality of life in somatization disorder was significantly associated with disability, symptom profile using PHQ-15, PHQ-9, and GAD-7. 25(OH)D levels were deficient in 56.31% of the study population. Conclusion: The high somatic symptom severity in majority of patients suffering from somatization disorder needs more attention from psychiatrists across cultures so that functional status and quality of life can be improved. Routine estimation of Vitamin D levels and correction of its deficiency may bring about symptomatic relief at an early stage, thereby reducing the morbidity associated with the disorder. |
first_indexed | 2024-12-10T09:57:23Z |
format | Article |
id | doaj.art-e47f0bcee36f48a7baa68fde6b0092e2 |
institution | Directory Open Access Journal |
issn | 0972-6748 0976-2795 |
language | English |
last_indexed | 2024-12-10T09:57:23Z |
publishDate | 2018-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Industrial Psychiatry Journal |
spelling | doaj.art-e47f0bcee36f48a7baa68fde6b0092e22022-12-22T01:53:27ZengWolters Kluwer Medknow PublicationsIndustrial Psychiatry Journal0972-67480976-27952018-01-01271879110.4103/ipj.ipj_73_1725 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatizationShruti SrivastavaManjeet Singh BhatiaPriyanka GautamIntroduction: Somatization disorder is a debilitating condition, in which patients have multiple physical complaints with no explained cause and no relief even after consultations. Aim: The present study examined the association of 25-hydroxyvitamin D (25[OH]D) levels, quality of life, disability, and symptom profile in long standing with somatization disorder. Methods: One-hundred three patients of somatization disorder suffering for ≥2 years, visiting psychiatry outpatient clinic during two consecutive summer season (April to June) of 2015–2016 were recruited. Symptom profile was studied using Patient-Health-Questionnaire (PHQ-15) items (somatic symptoms), PHQ-9 items (depressive symptoms), Generalized Anxiety Disorder-7 (GAD-7) item (anxiety symptoms).quality of life was assessed using the World Health Organization Quality of Life BREF 26 item, and disability measure was World Health Organization Disability Assessment Schedule (WHODAS) 2.0. 25(OH) D levels were estimated using chemiluminescence binding assay. Results: The poor quality of life in somatization disorder was significantly associated with disability, symptom profile using PHQ-15, PHQ-9, and GAD-7. 25(OH)D levels were deficient in 56.31% of the study population. Conclusion: The high somatic symptom severity in majority of patients suffering from somatization disorder needs more attention from psychiatrists across cultures so that functional status and quality of life can be improved. Routine estimation of Vitamin D levels and correction of its deficiency may bring about symptomatic relief at an early stage, thereby reducing the morbidity associated with the disorder.http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=87;epage=91;aulast=SrivastavaDisabilityquality of lifesomatizationVitamin D deficiency |
spellingShingle | Shruti Srivastava Manjeet Singh Bhatia Priyanka Gautam 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization Industrial Psychiatry Journal Disability quality of life somatization Vitamin D deficiency |
title | 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization |
title_full | 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization |
title_fullStr | 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization |
title_full_unstemmed | 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization |
title_short | 25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization |
title_sort | 25 hydroxyvitamin d levels quality of life and disability in long standing patients of somatization |
topic | Disability quality of life somatization Vitamin D deficiency |
url | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=87;epage=91;aulast=Srivastava |
work_keys_str_mv | AT shrutisrivastava 25hydroxyvitamindlevelsqualityoflifeanddisabilityinlongstandingpatientsofsomatization AT manjeetsinghbhatia 25hydroxyvitamindlevelsqualityoflifeanddisabilityinlongstandingpatientsofsomatization AT priyankagautam 25hydroxyvitamindlevelsqualityoflifeanddisabilityinlongstandingpatientsofsomatization |